This is a public edition of the seminar series in Foresight’s the Biotech and Health Extension sponsored by 100 Pus Capital.
Email Allison Duettmann, Foresight CEO, with questions: [email protected]
Join for the official online launch event for the Biomarkers of Aging Consortium
With Vadim Glayshev, Vittorio Sebastiano, and Mahdi Moqri who will be discussing Quantifying Aging and the Consortium.
Vadim Gladyshev is a Professor of Medicine at Harvard Medical School, Director of the Center for Redox Medicine at Brigham and Women’s Hospital, and Associate Member of the Broad Institute. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation and lifespan control using a combination of experimental and computational approaches. He has published more than 400 articles. Dr. Gladyshev is the recipient of NIH Pioneer, Transformative and Eureka awards and is an elected member of the National Academy of Sciences, USA.
Vittorio Sebastiano is an Associate Professor (Research) of Obstetrics and Gynecology (Reproductive and Stem Cell Biology) at Stanford University. He is an expert in Stem Cells, Developmental Biology, Molecular Biology, Tissue Engineering, Genome Editing, Cell Culture, and Immunohistochemistry.
Mahdi Moqri is an NIH Postdoctoral Fellow in Aging Research at the Sebastiano Lab at the Institute for Stem Cell Biology and Regenerative Medicine at Stanford, and a visiting scholar at the Gladyshev Lab at Harvard Medical School. His current research is on epigenomics of aging and rejuvenation.
